View Older Stories

May 14, 2026 06:57AM Doximity Inc (DOCS) PT Lowered to $26 at Mizuho

May 14, 2026 06:53AM Doximity Inc (DOCS) PT Lowered to $30 at Canaccord

May 14, 2026 06:52AM Raymond James Downgrades Doximity Inc (DOCS) to Outperform, 'Valuation Case Still Attractive'

May 14, 2026 05:45AM BTIG Downgrades Doximity Inc (DOCS) to Neutral

May 14, 2026 04:59AM Doximity Inc (DOCS) PT Lowered to $19 at Evercore ISI

May 14, 2026 04:39AM Doximity Inc (DOCS) PT Lowered to $27 at Needham

May 14, 2026 04:27AM Doximity Inc (DOCS) PT Lowered to $19 at Truist Securities

May 14, 2026 03:16AM Baird Downgrades Doximity Inc (DOCS) to Neutral

May 14, 2026 03:13AM Jefferies Downgrades Doximity Inc (DOCS) to Hold

May 14, 2026 02:55AM KeyBanc Downgrades Doximity Inc (DOCS) to Sector Weight

May 14, 2026 02:52AM Wells Fargo Downgrades Doximity Inc (DOCS) to Equal Weight

May 13, 2026 04:35PM After-hours movers: CSCO, HPE, DOCS, STUB, STAA, GO

May 13, 2026 04:03PM Doximity integrates AI tools with Aledade's care platform

May 13, 2026 04:02PM Doximity, Inc. (DOCS) Misses Q4 EPS by 2c, Beats on Revenue; Offers FY26 Revenue Guidance

May 5, 2026 05:19AM BTIG highlights key trends from Boston Digital Health Summit

Apr 23, 2026 09:21AM Raymond James on Doximity Inc (DOCS): 'We don’t view the news positively'

Apr 20, 2026 09:55AM Raymond James Reiterates Strong Buy Rating on Doximity Inc (DOCS)

Apr 20, 2026 06:19AM Doximity Inc (DOCS) PT Raised to $34 at Leerink Partners

Apr 20, 2026 12:45AM Truist Securities Downgrades Doximity Inc (DOCS) to Hold

Apr 15, 2026 06:59AM Doximity Inc (DOCS) PT Lowered to $47 at BofA Securities, 'Some incremental positives against market concerns'

Apr 8, 2026 05:36AM Evercore ISI Downgrades Doximity Inc (DOCS) to In Line

Mar 17, 2026 04:05PM Freedom Capital Markets Starts Doximity Inc (DOCS) at Buy

Feb 20, 2026 08:26AM Doximity Inc (DOCS) PT Raised to $42 at Piper Sandler

Feb 14, 2026 10:00AM Which healthcare stocks are at risk from AI and which to buy

Feb 10, 2026 06:38AM Doximity Inc (DOCS) PT Lowered to $34 at Mizuho

Feb 9, 2026 12:22AM Canaccord Genuity Upgrades Doximity Inc (DOCS) to Buy

Feb 9, 2026 12:22AM Canaccord Genuity Upgrades Doximity Inc (DOCS) to Buy

Feb 8, 2026 10:00AM Investor overreaction is a buying opportunity in this MedTech stock: Morgan Stanley

Feb 6, 2026 08:59AM Doximity Inc (DOCS) PT Lowered to $25 at BMO Capital Amid Near-Term Headwinds

Feb 6, 2026 06:01AM Doximity Inc (DOCS) PT Lowered to $37 at Truist Securities

Feb 6, 2026 05:58AM Doximity Inc (DOCS) PT Lowered to $55 at Needham

Feb 6, 2026 05:42AM Doximity Inc (DOCS) PT Lowered to $40 at Piper Sandler

Feb 6, 2026 02:34AM JPMorgan Upgrades Doximity Inc (DOCS) to Neutral

Feb 5, 2026 04:36PM After-hours movers: Amazon, Roblox, Bloom Energy, Reddit, Molina Health and more

Feb 5, 2026 04:03PM Doximity, Inc. (DOCS) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance

Jan 30, 2026 05:27AM Doximity Inc (DOCS) PT Lowered to $70 at BofA Securities

Jan 9, 2026 06:09AM Goldman Sachs Upgrades Doximity Inc (DOCS) to Buy

Jan 9, 2026 03:27AM Raymond James on Doximity Inc (DOCS): 'We likely aren’t done with the competitive dynamic narrative'

Jan 8, 2026 04:29PM RBC Capital Starts Doximity Inc (DOCS) at Outperform

Jan 8, 2026 01:46PM Raymond James comments on Doximity, Inc. (DOCS) post webinar: 'The expert hasn’t seen any changes to budgets for DTC spending'

Jan 8, 2026 09:24AM Truist Securities Upgrades Doximity Inc (DOCS) to Buy

Jan 8, 2026 05:44AM Evercore ISI on Doximity Inc (DOCS): 'we expect Doximity to remain the anchor professional and commercial platform'

Dec 31, 2025 06:00AM This software stock has a 'Strong Buy' rating at Raymond James

Dec 30, 2025 04:10PM Doximity settles securities lawsuit for $31 million

Dec 29, 2025 04:07AM Raymond James on Doximity Inc (DOCS): 'We would continue to buy shares on the recent pullback'

Dec 18, 2025 08:00AM Piper are buyers of 'these high quality, profitable, growth' stocks

Dec 16, 2025 07:34AM Piper Sandler: 'We Would be Buyers of DOCS and PHR Following Pharma Marketing KOL Lunch'

Dec 16, 2025 06:00AM BofA Securities on Doximity Inc (DOCS): 'No shift from DTC, but HCP growth is accelerating'

Dec 16, 2025 05:59AM Piper: 'We Would be Buyers of DOCS and PHR Following Pharma Marketing KOL Lunch in Boston'

Dec 15, 2025 02:40AM Morgan Stanley Upgrades Doximity Inc (DOCS) to Overweight

View Older Stories